Evidence map›Paper›PMID 33913620›Full record

ArticlePediatric blood & cancer2021

COVID-19 has changed the way we think about training future pediatric hematologists/oncologists.

Scott Moerdler, Bradley Gampel, Jennifer M Levine, Alexander Chou, Pallavi Madhusoodhan, Jennifer A Oberg, Joanna Pierro, Stephen S Roberts, Prakash Satwani

Abstract read
In one paragraph

Article in Pediatric blood & cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Scott MoerdlerRutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.ORCID https://orcid.org/0000-0002-2067-4817
Bradley GampelDepartment of Pediatrics, Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, New York-Presbyterian Morgan Stanley Children's Hospital, Columbia University Medical Center, New York, New York, USA.
Jennifer M LevineDivision of Pediatric Hematology and Oncology, Weill Cornell Medicine, New York, New York, USA.
Alexander ChouDivision of Pediatric Hematology, Oncology and Cellular Therapy, Children's Hospital at Montefiore, Bronx, New York, USA.ORCID https://orcid.org/0000-0002-7926-3326
Pallavi MadhusoodhanDepartment of Pediatrics, Division of Pediatric Hematology-Oncology, Mount Sinai Kravis Children's Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Jennifer A ObergDepartment of Pediatrics, Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, New York-Presbyterian Morgan Stanley Children's Hospital, Columbia University Medical Center, New York, New York, USA.ORCID https://orcid.org/0000-0002-9135-3391
Joanna PierroDivision of Pediatric Hematology Oncology, Northwell Health, Staten Island University Hospital, Staten Island, New York, USA.
Stephen S RobertsDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0001-8258-756X
Prakash SatwaniDepartment of Pediatrics, Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, New York-Presbyterian Morgan Stanley Children's Hospital, Columbia University Medical Center, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has upended medical practice and education, but has also catalyzed enhancements in the field. Early on, a local group of researchers united to investigate the impact of the pandemic on pediatric hematology oncology (PHO). From this group, a regional educational series was established, "virtual-Symposium of Pediatric Hematology/Oncology of New York" (v-SYMPHONY). The implementation of these endeavors while PHO fellowship applications are declining has highlighted our perceptions that education, mentoring, and career expectations are not keeping up with the needs of current trainees. We describe our regional experience joining together to further education and research, and reflect on the current landscape of PHO training and workforce.

Indexed as

COVID-19Education, Medical, GraduateSARS-CoV-2Congresses as TopicHematologyHumansMedical OncologyPediatricsCOVID-19pediatric hematology oncology fellowship training

Identifiers

PMID33913620
PMCPMC8209867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.